17
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, Density Functional Theory and Kinetic Studies of Aminopyridine Based α-glucosidase Inhibitors

, , , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 1757-1772 | Received 03 May 2023, Accepted 29 Aug 2023, Published online: 16 Oct 2023

References

  • Cohen P , GoedertM. GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug Discov.3(6), 479–487 (2004).
  • Rahman S , RahmanT , IsmailAAS , RashidARA. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes. Metab.9(6), 767–780 (2007).
  • Zeng Z , YinX , WangXet al. Synthesis of water soluble pentacyclic dihydroxyterpene carboxylic acid derivatives coupled amino acids and their inhibition activities on α-glucosidase. Bioorg. Chem.86, 277–287 (2019).
  • Giovannucci E , HarlanDM , ArcherMCet al. Diabetes and cancer: a consensus report. Diabetes Care33(7), 1674–1685 (2010).
  • Reusch JE , MansonJE. Management of type 2 diabetes in 2017: getting to goal. JAMA317(10), 1015–1016 (2017).
  • Van Herpt TT , LigthartS , LeeningMJet al. Lifetime risk to progress from pre-diabetes to type 2 diabetes among women and men: comparison between American Diabetes Association and World Health Organization diagnostic criteria. BMJ Open Diabetes Res. Care8(2), e001529 (2020).
  • Ford ES . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care28(7), 1769–1778 (2005).
  • Almogbel E , RasheedN. Protein mediated oxidative stress in patients with diabetes and its associated neuropathy: correlation with protein carbonylation and disease activity markers. J. Clin. Diagn. Res.11(2), BC21 (2017).
  • Bajaj S . RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017. Int. J. Diabetes Dev. Ctries38(1), 1–115 (2018).
  • Jaacks LM , SiegelKR , GujralUP , NarayanKV. Type 2 diabetes: a 21st century epidemic. Best Pract. Res. Clin. Endocrinol. Metab.30(3), 331–343 (2016).
  • Ye GJ , LanT , HuangZXet al. Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion. Eur. J. Med. Chem.177, 362–373 (2019).
  • Proença C , FreitasM , RibeiroDet al. α-Glucosidase inhibition by flavonoids: an in vitro and in silico structure-activity relationship study. J. Enzyme Inhib. Med. Chem.32(1), 1216–1228 (2017).
  • Ajish KR , AntuKA , RiyaMPet al. Studies on α-glucosidase, aldose reductase and glycation inhibitory properties of sesquiterpenes and flavonoids of Zingiber zerumbet Smith. Nat. Prod. Res.29(10), 947–952 (2015).
  • Chai T , MohanM , OngH , WongF. Antioxidant, iron-chelating and anti-glucosidase activities of Typha domingensis Pers (Typhaceae). Trop. J. Pharm. Res.13(1), 67–72 (2014).
  • Van De Laar FA , LucassenPL , AkkermansRPet al. α-Glucosidase inhibitors for patients with type 2 diabetes: results from a Cochrane systematic review and meta-analysis. Diabetes Care28(1), 154–163 (2005).
  • Hanefeld M , CagatayM , PetrowitschTet al. Acarbose reduces the risk for myocardial infarction in type 2 diabetic patients: meta-analysis of seven long-term studies. Eur. Heart J.25(1), 10–16 (2004).
  • Ihara Y , ToyokuniS , UchidaKet al. Pancreatic B-cells of GK rats, a model of type 2 diabetes. Diabetes48, 927–932 (1999).
  • Drent ML , TollefsenAT , Van HeusdenFHet al. Dose-dependent efficacy of miglitol, an α-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study. Diabetes, Nutr. Metab.15(3), 152 (2002).
  • Kim Y-M , WangM-H , RheeH-I. A novel α-glucosidase inhibitor from pine bark. Carbohydr. Res.339(3), 715–717 (2004).
  • Dirir AM , DaouM , YousefAF , YousefLF. A review of α-glucosidase inhibitors from plants as potential candidates for the treatment of type-2 diabetes. Phytochem. Rev.21(4), 1049–1079 (2022).
  • Saeed A , AbbasN , RafiqueHet al. Synthesis, characterization and antibacterial activity of some 1-aroyl-3-aryl thioureas. Chemistry18(5), 152–158 (2009).
  • Masereel B , LambertDM , DognéJMet al. Anticonvulsant activity of pyrid-3-yl-sulfonyl ureas and thioureas. Epilepsia38(3), 334–337 (1997).
  • Turan-Zitouni G , ÇavuşoğluBK , SağlıkBN , ÇevikUA. Synthesis and antimicrobial activities of some novel thiazole compounds. Turkish J. Biochem.43(3), 220–227 (2017).
  • Rosove MH . Agranulocytosis and antithyroid drugs. West. J. Med.126(5), 339 (1977).
  • Sondhi SM , SharmaVK , SinghalNet al. Synthesis and anti-inflammatory activity evaluation of some acridinyl amino antipyrine, acridinyl amino anthraquinone, acridino thiourea and thiazolino thiourea derivatives. Phosphorus Sulfur Silicon Relat. Elem.156(1), 21–33 (2000).
  • Rao RN , ChandaK. 2-Aminopyridine-an unsung hero in drug discovery. Chem. Commun.58(3), 343–382 (2022).
  • Kibou Z , AissaouiN , DaoudIet al. Efficient synthesis of 2-aminopyridine derivatives: antibacterial activity assessment and molecular docking studies. Molecules27(11), 3439 (2022).
  • Comins DL . Synthesis of MAPA reagents and 2-alkyl(aryl)aminopyridines from 2-bromopyridine using the goldberg reaction. Molecules27, 1833 (2022).
  • Shakeel A , AltafAA , QureshiAM , BadshahA. Thiourea derivatives in drug design and medicinal chemistry: A short review. J. Drug Des. Med. Chem.2(1), 10 (2016).
  • Gackowski M , MadriwalaB , KobaM. In silico design, docking simulation, and ANN-QSAR model for predicting the anticoagulant activity of thiourea isosteviol compounds as FXa inhibitors. Chem. Pap.77, 7027–7044 (2023).
  • Dey S , PatelA , HaloiNet al. Quinoline thiourea-based zinc ionophores with antibacterial activity. J. Med. Chem.66(16), 11078–11093 (2023).
  • Ahmed A , AhmedA , ChannarPAet al. Synthesis, single crystal XRD, in-silico and in-vitro studies of alkyl substituted acyl thiourea as carbonic anhydrase inhibitor. J. Mol. Struct.1292(7), 136187 (2023).
  • Sun GX , YangMY , ShiYXet al. Microwave assistant synthesis, antifungal activity and DFT theoretical study of some novel 1,2,4-triazole derivatives containing pyridine moiety. Int. J. Mol. Sci.15(5), 8075–8090 (2014).
  • Oki T , MatsuiT , OsajimaY. Inhibitory effect of α-glucosidase inhibitors varies according to its origin. J. Agric. Food Chem.47(2), 550–553 (1999).
  • Choudhary MI , IsmailM , ShaariKet al. cis-Clerodane-type furanoditerpenoids from Tinospora crispa. J. Nat. Prod.73(4), 541–547 (2010).
  • Mumit MA , PalTK , AlamMAet al. DFT studies on vibrational and electronic spectra, HOMO-LUMO, MEP, HOMA, NBO and molecular docking analysis of benzyl-3-N-(2,4,5-trimethoxyphenylmethylene) hydrazinecarbodithioate. J. Mol. Struct.1220, 128715 (2020).
  • Abuelizz HA , IwanaNAN , AhmadRet al. Synthesis, biological activity and molecular docking of new tricyclic series as α-glucosidase inhibitors. BMC Chem.13(1), 1–14 (2019).
  • Peytam F , TakalloobanafshiG , SaadattalabTet al. Design, synthesis, molecular docking, and in vitro α-glucosidase inhibitory activities of novel 3-amino-2,4-diarylbenzo[4,5]imidazo[1,2-a]pyrimidines against yeast and rat α-glucosidase. Sci. Rep.11(1), 1–18 (2021).
  • Kausar N , UllahS , KhanMAet al. Celebrex derivatives: synthesis, α-glucosidase inhibition, crystal structures and molecular docking studies. Bioorg. Chem.106, 104499 (2021).
  • Shah S , JavaidK , ZafarHet al. Synthesis, and In vitro and in silico α-glucosidase inhibitory studies of 5-chloro-2-aryl benzo[d]thiazoles. Bioorg. Chem.78, 269–279 (2018).
  • Ahmed A , ShafiqueI , SaeedAet al. Nimesulide linked acyl thioureas potent carbonic anhydrase I, II and α-glucosidase inhibitors: design, synthesis and molecular docking studies. EJMECH Reports6, 100082 (2022).
  • Saeedi M , Raeisi-NafchiM , SobhaniSet al. Synthesis of 4-alkylaminoimidazo[1,2-a]pyridines linked to carbamate moiety as potent α-glucosidase inhibitors. Mol. Divers25, 2399–2409 (2021).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.